The interleukin-6 promoter -597/-572/-174genotype does not affect interleukin-6 production in hemodialysis patients

Journal of Interferon and Cytokine Research

Volumn 31, Issue 8, 2011, Pages 639-642

  Schulte, Friederike ^a   Schnülle, Peter ^a   Bugert, Peter ^a   Klüter, Harald ^a   Müller Steinhardt, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HUMAN; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; GENOTYPE; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-6; KIDNEY TRANSPLANTATION; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RENAL DIALYSIS; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 80051481306     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2010.0141     Document Type: Article

References (18)

1. Agrawal S, Gollapudi P, Elahimehr R, Pahl MV, Vaziri ND. 2010. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant 25(3):737-746.
2. Breulmann B, Bantis C, Siekierka M, Blume C, Aker S, Kuhr N, Grabensee B, Ivens K. 2007. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin Transplant 21(5):615-621. (Pubitemid 47399425)
3. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis. J Clin Invest 102(7):1369-1376. (Pubitemid 28467565)
4. Gadelha SR, Junior Alcantara LC, Costa GC, Acosta AX, Rios D, Kashima S, Covas DT, Galvao-Castro B. 2008. Correlationbetween polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals. J Med Virol 80(12):2141-2146.
5. Girndt M, Heine GH, Kohler H. 2006. Gene polymorphism association studies in dialysis: Anemia and host immunity. Semin Dial 19(3):227-231. (Pubitemid 43742659)
6. Härtel C, Iblher P, Puzik A, Wortmeier K, Ebel B, Schultz C, Müller-Steinhardt M. 2006. Immunosuppressive activity of the immunophilin-binding drug Sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes. Scand J Immunol 63(1):26-34.
7. He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, Demeo DL, Litonjua AA, Silverman E, Connett JE, Anthonisen NR, Wise R, Pare P, Sandford AJ. 2009. Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 64(8):698-704.
8. Kruger B, Walberer A, Farkas S, Tokmak F, Obed A, Schenker P, Henning B, Schlitt HJ, Kramer BK, Banas B. 2009. The impact of "high-producer" interleukin-6 haplotypes on cardiovascular morbidity and mortality in a kidney transplant population. Transplant Proc 41(6):2539-2543.
9. Malaponte G, Bevelacqua V, Fatuzzo P, Rapisarda F, Emmanuele G, Travali S, Mazzarino MC. 2002. IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age. Nephrol Dial Transplant 17(11):1964-1970. (Pubitemid 35277095)
10. Marshall SE, McLaren AJ, McKinney EF, Bird TG, Haldar NA, Bunce M, Morris PJ, Welsh KI. 2001. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 71(3):469-476. (Pubitemid 32175987)
11. Müller-Steinhardt M, Ebel B, Härtel C. 2007. The impact of interleukin-6 promoter -597/-572/-174genotype on interleukin- 6 production after lipopolysaccharide stimulation. Clin Exp Immunol 147(2):339-345. (Pubitemid 46096013)
12. Müller-Steinhardt M, Fricke L, Müller B, Ebel B, Kirchner H, Härtel C. 2004. Cooperative influence of the interleukin-6 promoter polymorphisms -597, -572 and -174 on long-term kidney allograft survival. Am J Transplant 4(3):402-406. (Pubitemid 38282296)
13. Müller-Steinhardt M, Kock N, Härtel C, Kirchner H, Steinhoff J. 2001. Production of monokines in patients under polysulphone haemodiafiltration is influenced by the ultrafiltration flow rate. Nephrol Dial Transplant 16(9):1830-1837. (Pubitemid 32821415)
14. Müller-Steinhardt M, Schulte F, Klüter H, Bugert P. 2009. Optimized PCR with sequence specific primers (PCR-SSP) for fast and efficient determination of Interleukin-6 Promoter -597/-572/-174Haplotypes. BMC Res Notes 2:245.
15. Ray A, LaForge KS, Sehgal PB. 1990. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif ) occlusion. Mol Cell Biol 10(11):5736-5746.
16. Sanchez-Velasco P, Rodrigo E, Fernandez-Fresnedo G, Ocejo-Vinyals JG, Ruiz JC, Arnau A, Leyva-Cobian F, Arias M. 2010. Influence of interleukin-6 promoter polymorphism -174 g/c on kidney graft outcome. Transplant Proc 42(8):2854-2855.
17. Terry CF, Loukaci V, Green FR. 2000. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275(24):18138-18144. (Pubitemid 30414764)
18. Tsai PC, Chen CJ, Lai HM, Chang SJ. 2008. Analysis of polymorphisms in the promoter region and protein levels of interleukin-6 gene among gout patients. Clin Exp Rheumatol 26(5):841-847.